Research company Envigo – formerly known as Huntindon Life Sciences – has appointed Patricia Henahan as its new chief financial officer.
Henahan brings 15 years of financial experience in the life science sector, including senior leadership roles at AstraZeneca, Eli Lilly and MedImmune.
Most recently, she served as vice president of finance for Hospira’s US commercial operations.
Brian Cass, chief executive officer at Envigo, said: “I am delighted that Pat has decided to join the team at Envigo.
“Her background in pharmaceuticals and experience across the research and development process will bring valuable insight to our strategic planning as we continue to position Envigo as a leading provider of contract services and research models globally.”